SCHEMBL4032905

SCHEMBL4032905

CC(=O)c1ccc(N2CCC(CC3CCN(C4CCC4)CC3)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.53
L3MBTL3 Q96JM7 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
MBTD1 Q05BQ5 1/20 0.51
TP53BP1 Q12888 1/20 0.51
L3MBTL4 Q8NA19 1/20 0.51
HRH3 Q9Y5N1 7/20 0.47
GPR119 Q8TDV5 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
HRH1 P35367 1/20 0.43
USP2 O75604 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209386 0.84 KMT2A (0.57) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL3767570 0.84 KMT2A (0.55) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL4036039 0.84 L3MBTL3 (0.48) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL4034760 0.83 KMT2A (0.51) KMT2AMEN1ALDH1A1MAPTHRH3
SCHEMBL3968371 0.83 KMT2A (0.74) KMT2AMEN1ALDH1A1MAPTL3MBTL3
Hydrochloric Acid SCHEMBL5213050 0.83 KMT2A (0.56) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL4035015 0.83 HRH3 (0.53) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL3773944 0.82 KMT2A (0.55) KMT2AMEN1ALDH1A1MAPTL3MBTL3
SCHEMBL4031778 0.82 HRH3 (0.66) ALDH1A1MAPTHRH3NPC1RAB9A
SCHEMBL4427879 0.82 KMT2A (0.57) KMT2AMEN1ALDH1A1MAPTL3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1789410-B1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2009-06-17 EP claimed
US-20080108624-A1 Methylene Dipiperidine Derivatives GLAXO GROUP LIMITED (GB) 2008-05-08 US claimed
US-7638631-B2 Methylene dipiperidine derivatives GLAXO GROUP LIMITED (GB) 2009-12-29 US disclosed
US-7638631-B2 Methylene dipiperidine derivatives GLAXO GROUP LIMITED (GB) 2009-12-29 US disclosed
US-7638631-B2 Methylene dipiperidine derivatives GLAXO GROUP LIMITED (GB) 2009-12-29 US disclosed
EP-1789410-B1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2009-06-17 EP disclosed
EP-1789410-B1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2009-06-17 EP disclosed
US-20080108624-A1 Methylene Dipiperidine Derivatives GLAXO GROUP LIMITED (GB) 2008-05-08 US disclosed
US-20080108624-A1 Methylene Dipiperidine Derivatives GLAXO GROUP LIMITED (GB) 2008-05-08 US disclosed
US-20080108624-A1 Methylene Dipiperidine Derivatives GLAXO GROUP LIMITED (GB) 2008-05-08 US disclosed
EP-1789410-A1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2007-05-30 EP disclosed
WO-2006029906-A1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108624-A1 Methylene Dipiperidine Derivatives DRD2, DRD4, PNMT KMT2A 713/4885MEN1 3050/4885ALDH1A1 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.